NanoViricides' NV-387 Shows 130% Survival Boost Against Measles
October 23, 2025 — NanoViricides' NV-387 drug candidate shows 130% survival improvement against Measles in animal studies. No approved Measles treatment exists, making this potential first-in-class therapy groundbreaking.